2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases
Methodological detailsGRADE methodology, AGREE criteria, systematic literature review, expert Voting Panel, consensus ≥70% agreement
- GRADE methodology
- AGREE criteria
- Systematic literature review
- Expert Voting Panel
- Consensus ≥70% agreement
Recommendations
As issued by the authors
Expanded indications for some vaccines in patients with rheumatic and musculoskeletal diseases (RMDs)
Guidance on whether to hold immunosuppressive medications or delay vaccination to maximize vaccine immunogenicity and efficacy
Safe approaches to the use of live attenuated vaccines in patients taking immunosuppressive medications
- Mostly conditional; low quality of evidence
Most recommendations are conditional and had low quality of supporting evidence
Original publication
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). Published 4 January 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →